Theralase Technologies Inc. V.TLT

What's Next?

[Eoganacht]

Given the stability of CRs after the 180 day assessment, and taking into account only patients who were CR at both their 90 day and 180 day assessments I think we can be confident that:

 

90 days from now we should be at a 450 day CR rate of 31%

(12 out of 39 should be CR)

 

180 days from now we should be at a 450 day CR rate of 34%

(14 out of 41 should be CR)

 

270 days from now we should be at a 450 day CR rate of 40%

(19 out of 47 should be CR)

 

Stellar results. And this includes the 12 undertreated patients.

[enriquesuave]

Nice Eoganacht.  Without 12 undertreated patients we would may e be looking at 50-55% 450 CR rate Imo. With only 2 treatments. I can imagine that NR and IR patients will eventually be given 3-4 treatments and perhaps we get another 10-20 % increase in CR rate perhaps? 

[Eoganacht]

Right. And even if we are not allowed to remove the 12 undertreated, the results will still be by far the best out there. If we assume an (at least) 40% durable CR rate for the first half of the trial (52 patients) including the 12 undertreated, this will mean 21 of the first 52 patients were CR. If we further assume that none of the 12 undertreated attained a durable CR then the percentage of

[CancerSlayer]

  Yep Enrique... If our ACT is approved (have little doubt in my mind), clinicians will have the option to add a treatment(s) as they see fit for the more resistant/highly pre-treated patients...this is the art of medicine, which is unfortunately fading in general medicine & other specialties.  Regardless, practice guidelines are just that...guidelines.  They are not hard

[N0taP00p]

We have 37 that moved all the way to 450 days. Even after removing the 12 under-treated patients, we have enough data now to submit, as many have said. Wouldn't it be nice if the next AGM was about multiple offers for the company, based on BTD and AA? Please, ask me to vote on that. THUD. Just fell back down to earth. Patience is a hard virtue to learn, even after ten years.